NERx Biosciences
Pre-clinicalWelcome to NĒRx Biosciences, a pre-clinical stage biotechnology company developing novel anticancer therapeutics targeting DNA damage response (DDR) and DNA repair. NĒRx Biosciences has developed a novel strategy to realize the full therapeutic promise of the DDR, by targeting the proteins that detect DNA damage (DDR sensors), as opposed to proteins that react to the sensors (DNA kinases), to initiate DNA repair pathways. We are exploiting recent scientific advances in our knowledge of the un...
About
Welcome to NĒRx Biosciences, a pre-clinical stage biotechnology company developing novel anticancer therapeutics targeting DNA damage response (DDR) and DNA repair. NĒRx Biosciences has developed a novel strategy to realize the full therapeutic promise of the DDR, by targeting the proteins that detect DNA damage (DDR sensors), as opposed to proteins that react to the sensors (DNA kinases), to initiate DNA repair pathways. We are exploiting recent scientific advances in our knowledge of the un...
Funding History
1Total raised: $5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile